Data Bridge Market Research

Live Attenuated Vaccines Market 20202 Competitive Analysis: Sanofi, Emergent BioSolutions Inc, GlaxoSmithKline Plc, Daiichi Sankyo Company, Limited, AstraZeneca

Global Live Attenuated Vaccines Market - Industry Trends and Forecast to 2026


Pune, India -- (SBWIRE) -- 02/13/2020 -- Global Live Attenuated Vaccines Market By Product Type (Bacterial, Viral), Development (Tissue Culture, Embryonated Eggs, Live Animals), Indication (Tuberculosis, Measles, Rotavirus, Yellow Fever, Oral Polio, Others), Route of Administration (Oral, Injectable), End- Users (Hospitals, Specialty Clinics and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026

Get Exclusive Sample Copy of This Report Here @

Few of the major competitors currently working in the global live attenuated vaccines market are Sanofi, Emergent BioSolutions Inc, GlaxoSmithKline plc, Daiichi Sankyo Company, Limited, AstraZeneca, Biological E, SutroVax Inc, Polymun Scientific, Boehringer Ingelheim International GmbH, Merck & Co., Inc, Sanaria and others.

Global live attenuated vaccines market is expected to grow at a growing CAGR in the forecast period of 2019-2026. Increase in strategic alliances between the pharmaceuticals companies and high demand of disease specific novel therapies are the key factors that fueling the market growth.

Market Definition:

Bispecific antibodies are designed to elicit multifaceted biological effects that require simultaneous binding to two different antigen targets with one molecule. It can be employed wide range of therapeutics application including bind multiple targets, to block multiple pathogenic pathways, target tumor heterogeneity, increase specificity, synergistically induce enhanced therapeutic effects and others.

Market Drivers

Ongoing clinical trial  conducted by many pharmaceuticals industries is propelling the growth of this market
Growing prevalence of infections worldwide is boosting the market growth
High demand of disease specific novel treatment can also act as a market driver
The competitive scenario of market and strategic collaborations may boost the market position

Market Restraints

Limited operating revenue opportunities for research and development of targeted therapies by many pharmaceuticals is acting as a challenging factor for the growth of this market
Low healthcare budget in some developing countries is hamper the market growth
Scientific and development challenge in production of live attenuated vaccine is also hinders the market growth


By Product Type


By Development

Tissue Culture
Embryonated Eggs
Live Animals

By Indication

Yellow Fever
Oral Polio

By Route of Administration


By End Users

Specialty Clinics

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies

By Geography

North America
South America
Middle East & Africa

Enquire for customization in Report @

Key Developments in the Market:

In May 2019, Sanofi Pasteur Inc a subsidiary of Sanofi received approval from the FDA for Dengvaxia (Dengue Tetravalent Vaccine, Live) for the prevention of dengue disease caused by serotypes 1 – 4 of the virus in individuals 9 through 16 years of age in the United States. The approval of Dengvaxia provides critical medical prevention for patients living in U.S. dengue endemic areas.

Competitive Analysis:

Global live attenuated vaccines market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares global live attenuated vaccines market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

Current and future of global live attenuated vaccines market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players

View Detailed Table of Contents @

About Data Bridge Market Research
An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.


Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475